conjunction with the section headed warning on the …€¦ · global (cayman) limited, 89 nexus...
TRANSCRIPT
A. FURTHER INFORMATION ABOUT OUR COMPANY
1. Incorporation of our Company
Our Company was incorporated in the Cayman Islands under the Companies Law as an
exempted company with limited liability on 21 February 2017. Our registered office is at Ogier
Global (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman
Islands. Our Company has been registered as a non-Hong Kong company under Part 16 of the
Companies Ordinance on 10 April 2019 and the principal place of business in Hong Kong is at
Room 3, 27th Floor, Ho King Commercial Centre, No. 2–16 Fa Yuen Street, Mongkok, Kowloon,
Hong Kong. Mr. Ng Kin Sun has been appointed as an authorised representative of our Company
for the acceptance of service of process and notices on behalf of our Company in Hong Kong.
As our Company is incorporated in the Cayman Islands, it operates subject to the relevant
laws of the Cayman Islands and its constitution which comprises the Memorandum and the
Articles. A summary of the certain provisions of the Memorandum and the Articles, and relevant
aspects of the Companies Law is set out in Appendix IV to this document.
2. Changes in the share capital of our Company
(a) As at the date of incorporation of our Company, our Company had an authorised share
capital of US$50,000 divided into 500,000 Shares of par value of US$0.10 each. One
fully-paid Share was allotted and issued to the initial subscriber Sertus Nominees
(Cayman) Limited on 21 February 2017, which was subsequently transferred to Jianeng
on the same date.
(b) On the same date, Jianeng and Haisen respectively applied for the allotment to them
separately 149,999 and 175,000 Shares at par value which were issued and allotted to
them on the same date.
(c) On 17 November 2017, our Company further issued and allotted 175,000 Shares at par
value, representing 35% of the enlarged issued share capital of our Company to Xiejia.
(d) After the aforesaid issue and allotment of Shares, our Company was indirectly owned
by Mr. Zheng Zhenzhong, Mr. Zheng Guodian and Mr. Zheng Guosi through their
respective investment holding vehicles (namely, Jianeng, Xiejia and Haisen) as to 30%,
35% and 35% respectively.
(e) On 5 October 2018, our Company, Jianeng, Haisen and Xiejia entered into the
Investment Agreement with APOC, a company incorporated in the BVI with limited
liabilities and wholly owned by Mr. Lee, an Independent Third Party and a passive
investor, pursuant to which our Company increased its authorised share capital from
[REDACTED] to [REDACTED] by the creation of [REDACTED] Shares and issued
and allotted the same to APOC, representing approximately 3% of the enlarged issued
share capital of our Company, at a consideration of RMB4,000,000. The said
consideration was arrived with reference to the historical financial results of our Group.
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-1 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(f) After the aforesaid issue and allotment of Shares, our Company was owned indirectly
by Mr. Zheng Zhenzhong, Mr. Zheng Guodian and Mr. Zheng Guosi and APOC as to
approximately 29.1%, 33.95%, 33.95% and 3% respectively.
(g) On [.], the Shareholders resolved to increase the authorised share capital of our
Company from US$51,546.4 to US$200,000 by the creation of an additional of
1,484,536 Shares, each ranking pari passu with the Shares then in issue in all respects.
(h) On [.], our Shareholders resolved, among other things that, all the issued and unissued
ordinary Shares at a par value of US$0.1 each will be subdivided into 1,000 Shares at a
par value of US$0.0001 each such that the authorised share capital of our Company
shall be US$200,000 divided into 2,000,000,000 Shares of par value of US$0.0001 each
and the issued share capital shall be US$51,546.4 divided into 515,464,000 Shares of
par value of US$0.0001 each.
(i) Immediately following completion of the [REDACTED] and the [REDACTED],
assuming that the [REDACTED] is not exercised and taking no account of any Shares
which may be issued upon the exercise of any options which may be granted under the
Share Option Scheme, the issued share capital of our Company will be [REDACTED]
divided into [REDACTED], all fully paid or credited as fully paid, and [REDACTED]
will remain unissued.
(j) Other than pursuant to the general mandate to issue Shares referred to in the paragraph
headed ‘‘A. Further information about our Company — 3. Resolutions in writing of the
Shareholders’’ in this appendix and pursuant to the Share Option Scheme, our Company
does not have any present intention to issue any of the authorised but unissued share
capital of our Company and, without prior approval of our Shareholders in general
meeting, no issue of Shares will be made which would effectively alter the control of
our Company.
(k) Save for the aforesaid and as mentioned in the section headed ‘‘History, development
and Reorganisation’’ in this document, there has been no alternation in our Company’s
share capital since its incorporation.
3. Resolutions in writing of the Shareholders
Pursuant to the written resolution passed by the Shareholders on [.]:
(a) our Company approved and adopted the Memorandum and the Articles with effect from
the [REDACTED], the terms of which are summarised in Appendix IV to this
document;
(b) the authorised share capital of our Company was increased from US$51,546.4 to
[US$200,000] by the creation of an additional 1,484,536 Shares at a par value of
US$0.1 each;
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-2 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(c) each issued and unissued ordinary shares of US$0.1 each of our Company be
subdivided into 1,000 ordinary Shares of US$0.0001 each such that the authorised share
capital of our Company shall be US$200,000 divided into 2,000,000,000 ordinary
Shares with a par value of US$0.0001 each;
(d) conditional on (i) the [REDACTED] granting the [REDACTED] of, and [REDACTED]
in, the Shares in issue, Shares to be issued pursuant to the [REDACTED] and the
Shares to be issued as mentioned in this document (including any Shares which may be
issued pursuant to the exercise of the options granted under the Share Option Scheme);
and (ii) the obligations of the [REDACTED] under the [REDACTED] becoming
unconditional and not being terminated in accordance with the terms therein or
otherwise, in each case on or before such dates as may be specified in the
[REDACTED]:
(i) the [REDACTED] was approved and the Directors were authorised to allot and
issue the new [REDACTED] pursuant to the [REDACTED];
(ii) the rules of the Share Option Scheme, the principal terms of which are set out in
the paragraph headed ‘‘D. Other information — 1. Share Option Scheme’’ in this
appendix, were approved and adopted and our Directors were authorised to grant
options to subscribe for Shares thereunder and to allot, issue and deal with Shares
pursuant to the exercise of options granted under the Share Option Scheme; and
(iii) conditional on the share premium account of our Company being credited as a
result of the issue of the [REDACTED] by our Company pursuant to the
[REDACTED], our Directors were authorised to capitalise an amount of
[REDACTED] standing to the credit of the share premium account of our
Company by applying such sum in paying up in full at par [REDACTED],
[REDACTED], [REDACTED] and [REDACTED], such Shares to be allotted and
issued to Haisen, Xiejia, Jianeng and [REDACTED], respectively, immediately
prior to the [REDACTED].
(e) a general unconditional mandate was given to the Directors to issue, allot and deal with
(including the power to make an offer or agreement, or grant securities which would or
might require Shares to be allotted and issued), otherwise than pursuant to a rights issue
or pursuant to any scrip dividend schemes or similar arrangements providing for the
allotment and issue of Shares in lieu of the whole or part of a dividend on Shares in
accordance with the Articles or pursuant to the grant of options under the Share Option
Scheme or other similar arrangement or pursuant to a specific authority granted by the
shareholders of our Company in general meeting, unissued Shares with a total nominal
value not exceeding 20% of the aggregate nominal value of the share capital of our
Company in issue immediately following completion of the [REDACTED] and the
[REDACTED] (but taking no account of any Shares which may be allotted and issued
upon the exercise of the [REDACTED] or pursuant to the exercise of the options
granted under the Share Option Scheme), such mandate to remain in effect until the
conclusion of the next annual general meeting of our Company, or the expiration of the
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-3 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
period within which the next annual general meeting of our Company is required by the
Articles or any applicable laws to be held, or until revoked or varied by an ordinary
resolution of the shareholders in general meeting, whichever occurs first;
(f) a general unconditional mandate was given to the Directors authorising them to exercise
all the powers of our Company to repurchase its own Shares on the Stock Exchange or
on any other approved stock exchange on which the securities of our Company may be
listed and which is recognised by the SFC and the Stock Exchange for this purpose,
such number of Shares will represent up to 10% of the aggregate nominal value of the
Shares in issue immediately following the completion of the [REDACTED] and the
[REDACTED], such mandate to remain in effect until the conclusion of the next annual
general meeting of our Company, or the expiration of the period within which the next
annual general meeting of our Company is required to be held by the Articles or any
applicable laws, or until revoked or varied by an ordinary resolution of Shareholders in
general meeting, whichever occurs first;
(g) the general mandate mentioned in paragraph (e) above be extended by the addition to
the aggregate nominal value of the share capital of our Company which may be allotted,
or agreed conditionally or unconditionally to be issued and allotted by our Directors
pursuant to such general mandate of an amount representing the aggregate nominal
value of the share capital of our Company repurchased by our Company pursuant to the
mandate to purchase shares referred to in paragraph (f) above; and
(h) the Share Option Scheme was approved and adopted and our Directors were authorised
to grant options to subscribe for Shares thereunder and to issue, allot and deal with
Shares pursuant to the exercise of options granted under the Share Option Scheme.
4. Corporation reorganisation
The companies comprising our Group underwent the Reorganisation in preparation for the
[REDACTED] of our Shares on the Stock Exchange. Please refer to the section headed ‘‘History,
development and Reorganisation’’ in this document for further details relating to the
Reorganisation.
5. Changes in the share capital of subsidiaries
Our subsidiaries during the Track Record Period are set out in note 37 of the accountants’
report in Appendix I to this document.
Apart from the alternations disclosed in the section headed ‘‘History, development and
Reorganisation’’ in this document, there has been no alternation in the share capital of any of the
subsidiaries of our Company within the two years immediately preceding the date of this
document.
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-4 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
6. Repurchase of the Shares by our Company
(a) Provisions of the Listing Rules
The Listing Rules permit companies with a primary [REDACTED] on the Stock
Exchange to repurchase their securities on the Stock Exchange subject to certain restrictions,
the more important of which are summarised below:
i. Shareholder’s approval
All proposed repurchases of Shares (which must be fully paid up) by a company
with a primary [REDACTED] on the Stock Exchange must be approved in advance by
an ordinary resolution of the Shareholders in general meeting, either by way of general
mandate or by specific approval of a particular transaction.
Pursuant to a written shareholder’s resolution of our Company dated [.], a general
unconditional mandate (the ‘‘Repurchase Mandate’’) was given to the Directors
authorising any repurchase by our Company of Shares on the Stock Exchange or on any
other stock exchange on which the securities may be listed and which is recognised by
the SFC and the Stock Exchange for this purpose, of not more than 10% of the
aggregate nominal value of our Company’s share capital in issue immediately following
the completion of the [REDACTED] but excluding any Shares which may be issued
pursuant to the exercise of the [REDACTED] until at the conclusion of our next annual
general meeting, or the expiration of the period within which our Company’s next
annual general meeting is required to be held under any applicable laws of the Articles,
or the passing of an ordinary resolution by the Shareholders revoking or varying the
authority given to the Directors, whichever occurs first.
ii. Source of funds
Repurchases must be funded out of funds legally available for the purpose in
accordance with our Articles and the applicable laws and regulations of the Cayman
Islands. A listed company may not repurchase its own securities on the Stock Exchange
for a consideration other than cash or for settlement otherwise than in accordance with
the trading rules of the Stock Exchange.
iii. Trading restrictions
The total number of Shares which our Company may repurchase is up to 10% of
the total number of our Shares in issue immediately after the completion of the
[REDACTED] (but not taking into account any Shares which may be issued pursuant to
the exercise of the [REDACTED]). Our Company may not issue or announce a
proposed issue of Shares for a period of 30 days immediately following a repurchase of
Shares without the prior approval of the Stock Exchange. Our Company is also
prohibited from repurchasing Shares on the Stock Exchange if the repurchase would
result in the number of listed Shares which are in the hands of the public falling below
the relevant prescribed minimum percentage as required by the Stock Exchange. Our
Company is required to procure that the broker appointed by our Company to effect a
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-5 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
repurchase of Shares discloses to the Stock Exchange such information with respect to
the repurchase as the Stock Exchange may require. As required by the prevailing
requirements of the Listing Rules, an issuer shall not purchase its shares on the Stock
Exchange if the purchase price is higher by 5% or more than the average closing market
price for the five preceding trading days on which its shares were traded on the Stock
Exchange.
iv. Status of repurchased Shares
All repurchased Shares (whether effected on the Stock Exchange or otherwise)
will be automatically delisted and the certificates for those Shares must be cancelled
and destroyed. Under the Cayman Companies Law, a company’s repurchased shares
shall be treated as cancelled and the amount of the company’s issued share capital shall
be reduced by the aggregate value of the repurchased shares accordingly although the
authorised share capital of the company will not be reduced.
v. Suspension of repurchase
Pursuant to the Listing Rules, our Company may not make any repurchases of
Shares after inside information has come to its knowledge until the information is made
publicly available. In particular, under the requirements of the Listing Rules in force as
at the Latest Practicable Date, during the period of one month immediately preceding
the earlier of:
(i) the date of the Board meeting (as such date is first notified to the Stock
Exchange in accordance with the Listing Rules) for the approval of our
Company’s results for any year, half year, quarterly or any other interim
period (whether or not required under the Listing Rules); and
(ii) the deadline for our Company to publish an announcement of our Company’s
results for any year or half-year under the Listing Rules, or quarterly or any
other interim period (whether or not required under the Listing Rules), and
in each case ending on the date of the results announcement,
our Company may not repurchase Shares on the Stock Exchange unless the
circumstances are exceptional.
vi. Procedural and reporting requirements
As required by the Listing Rules, repurchases of Shares on the Stock Exchange or
otherwise must be reported to the Stock Exchange not later than 30 minutes before the
earlier of the commencement of the morning trading session or any pre-opening session
on the Stock Exchange business day following any day on which our Company may
make a purchase of Shares. The report must state the total number of Shares purchased
the previous day, the purchase price per Share or the highest and lowest prices paid for
such purchases. In addition, our Company’s annual report is required to disclose details
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-6 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
regarding repurchases of Shares made during the year, including a monthly analysis of
the number of shares repurchased, the purchase price per Share or the highest and
lowest price paid for all such purchases, where relevant, and the aggregate prices paid.
vii. Connected persons
A company is prohibited from knowingly repurchasing securities on the Stock
Exchange from a connected person (as defined in the Listing Rules) and a connected
person shall not knowingly sell its securities to the company on the Stock Exchange.
(b) Reasons for repurchase
Our Directors believe that it is in our and our Shareholders’ best interests for our
Directors to have general authority to execute repurchases of our Shares in the market. Such
repurchases may, depending on market conditions and funding arrangements at the time, lead
to an enhancement of the net asset value per Share and/or earnings per Share and will only be
made where our Directors believe that such repurchases will benefit our Company and our
Shareholders.
(c) Funding of repurchase
In repurchasing securities, we may only apply funds legally available for such purpose
in accordance with our Memorandum and Articles of Association, the Cayman Companies
Law or any other applicable laws of the Cayman Islands and the Listing Rules.
On the basis of the current financial position of our Company as disclosed in this
document and taking into account the current working capital position of our Company, our
Directors believe that, if the repurchase mandate were to be exercised in full, it might have a
material adverse effect on our working capital and/or the gearing position as compared with
the position disclosed in this document. However, our Directors do not propose to exercise
the repurchase mandate to such an extent as would, in the circumstances, have a material
adverse effect on the working capital requirements of our Company or the gearing levels
which, in the opinion of our Directors, are from time to time appropriate for us.
The exercise in full of the current repurchase mandate, on the basis of [REDACTED] in
issue immediately following the completion of the [REDACTED], assuming that the
[REDACTED] is not exercised, could accordingly result in up to [REDACTED] being
repurchased by us during the relevant period.
(d) General
None of our Directors or, to the best of their knowledge, having made all reasonable
inquiries, any of their associates (as defined in the Listing Rules) currently intends to sell any
of our Shares to us or our subsidiaries.
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-7 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
Our Directors have undertaken to the Stock Exchange that, so far as the same may be
applicable, they will exercise the repurchase mandate in accordance with the Listing Rules,
the Memorandum and Articles of Association, the Cayman Companies Law and any other
applicable laws of the Cayman Islands.
If, as a result of any repurchase of our Shares pursuant to the repurchase mandate, a
shareholder’s proportionate interest in our voting rights is increased, such increase will be
treated as an acquisition for the purposes of the Takeovers Code. Accordingly, a Shareholder
or a group of Shareholders acting in concert, depending on the level of increase of the
Shareholders interest, could obtain or consolidate control of us and become obliged to make a
mandatory offer in accordance with Rule 26 of the Takeovers Code. Our Directors are not
aware of any consequences of repurchases which could arise under the Takeovers Code if the
repurchase mandate is exercised.
No connected person, as defined in the Listing Rules, has notified us that he/she/it has a
present intention to sell his/her/its Shares to us, or has undertaken not to do so, if the
repurchase mandate is exercised.
B. FURTHER INFORMATION ABOUT OUR BUSINESS
1. Summary of material contracts
We have entered into the following contracts (not being contracts entered into in the ordinary
course of business) within the two years preceding the date of this document and are or may be
material:
Agreements relating to transfer of equity interest of subsidiaries
(a) an equity transfer agreement dated 14 September 2018 entered into between Junwo as
transferee and Mr. Zheng Zhenzhong as transferor in relation to the transfer of 29.1%
equity interest in Coolsa Food at a consideration of RMB1,455,000;
(b) an equity transfer agreement dated 14 September 2018 entered into between Junwo as
transferee and Mr. Zheng Guosi as transferor in relation to the transfer of 33.95%
equity interest in Coolsa Food at a consideration of RMB1,697,500;
(c) an equity transfer agreement dated 14 September 2018 entered into between Junwo as
transferee and Mr. Zheng Guodian as transferor in relation to the transfer of 33.95%
equity interest in Coolsa Food at a consideration of RMB1,697,500;
(d) an equity transfer agreement dated 5 October 2018 entered into between Junwo as
transferee and APOC HK as transferor in relation to the transfer of 3% equity interest in
Coolsa Food at a consideration of RMB150,000;
(e) an equity transfer agreement dated 22 October 2018 entered into between Coolsa Food
as transferee and Mr. Zheng Zhenzhong as transferor in relation to the transfer of 30%
equity interest in Jiujiuwang Food at a consideration of RMB24,000,000;
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-8 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(f) an equity transfer agreement dated 22 October 2018 entered into between Coolsa Food
as transferee and Mr. Zheng Guosi as transferor in relation to the transfer of 35% equity
interest in Jiujiuwang Food at a consideration of RMB28,000,000;
(g) an equity transfer agreement dated 22 October 2018 entered into between Coolsa Food
as transferee and Mr. Zheng Guodian as transferor in relation to the transfer of 35%
equity interest in Jiujiuwang Food at a consideration of RMB28,000,000;
(h) an equity transfer agreement dated 29 December 2018 entered into between Jiujiuwang
Food as transferee and Mr. Zheng Zhenzhong as transferor in relation to the transfer of
20% equity interest in Jiujiuwang Co at nil consideration;
(i) an equity transfer agreement dated 29 December 2018 entered into between Jiujiuwang
Food as transferee and Mr. Zheng Guosi as transferor in relation to the transfer of 40%
equity interest in Jiujiuwang Co at nil consideration;
(j) an equity transfer agreement dated 29 December 2018 entered into between Jiujiuwang
Food as transferee and Mr. Zheng Guodian as transferor in relation to the transfer of
40% equity interest in Jiujiuwang Co at nil consideration;
Agreements relating to purchase of machinery and production line
(k) a sale and purchase agreement dated 8 May 2017 entered into between Jiujiuwang Food
and Chengdu Sanke Industry Co., Ltd. (成都三可實業有限公司), pursuant to which
Chengdu Sanke Industry Co., Ltd. agreed to sell a carton packaging machine to
Jiujiuwang Food;
(l) a sale and purchase agreement dated 16 June 2017 entered into between Jiujiuwang
Food and Chengdu Sanke Industry Co., Ltd. (成都三可實業有限公司), pursuant to
which Chengdu Sanke Industry Co., Ltd. agreed to sell a production line for
manufacture of chocolate-made products to Jiujiuwang Food;
(m) a sale and purchase agreement dated 3 September 2017 entered into between Jiujiuwang
Food and Chengdu Sanke Industry Co., Ltd. (成都三可實業有限公司), pursuant to
which Chengdu Sanke Industry Co., Ltd. agreed to sell an automatic double discharge
high speed machine for manufacture of tablet candies to Jiujiuwang Food;
(n) a sale and purchase agreement dated 28 June 2018 entered into between Jiujiuwang
Food and Jinjiang City Hengsong Machinery Manufacturing Co, Ltd.* (晉江市恒松機械
製造有限公司), pursuant to which Jinjiang City Hengsong Machinery Manufacturing
Co, Ltd. agreed to sell a demoulding and casting machine to Jiujiuwang Food;
(o) a sale and purchase agreement dated 28 June 2018 entered into between Jiujiuwang
Food and Chengdu Sanke Industry Co., Ltd. (成都三可實業有限公司), pursuant to
which Chengdu Sanke Industry Co., Ltd. agreed to sell a production line for
manufacture of jelly candies to Jiujiuwang Food;
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-9 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(p) a sale and purchase agreement dated 27 September 2018 entered into between
Jiujiuwang Food and Chengdu Sanke Industry Co., Ltd. (成都三可實業有限公司),
pursuant to which Chengdu Sanke Industry Co., Ltd. agreed to sell various machines to
Jiujiuwang Food;
(q) a sale and purchase agreement dated 28 September 2018 entered into between
Jiujiuwang Food and Chengdu Sanke Industry Co., Ltd. (成都三可實業有限公司),
pursuant to which Chengdu Sanke Industry Co., Ltd. agreed to sell various machines to
Jiujiuwang Food;
(r) a sale and purchase agreement dated 4 January 2019 entered into between Jiujiuwang
Food and Chengdu Sanke Industry Co., Ltd. (成都三可實業有限公司), pursuant to
which Chengdu Sanke Industry Co., Ltd. agreed to sell various machines to Jiujiuwang
Food;
(s) a sale and purchase agreement dated 13 March 2019 entered into between Jiujiuwang
Food and Hanlin Aerospace (Tianjin) Industrial Co., Ltd.* (翰林航宇(天津)實業有限公
司), pursuant to which Hanlin Aerospace (Tianjin) Industrial Co., Ltd. agreed to sell
various machines to Jiujiuwang Food;
(t) a sale and purchase agreement dated 18 March 2019 entered into between Jiujiuwang
Food and Hanlin Aerospace (Tianjin) Industrial Co., Ltd.* (翰林航宇(天津)實業有限公
司), pursuant to which Hanlin Aerospace (Tianjin) Industrial Co., Ltd. agreed to sell
various machines to Jiujiuwang Food;
Other agreements
(u) a compensation and settlement for land expropriation agreement dated 3 May 2017
entered into between Jiujiuwang Food and State-owned Land Resources Bureau of
Jinjiang City* (晉江市國土資源局), pursuant to which Jiujiuwang Food agreed to the
expropriation of a parcel of land by Bureau of Land and Resources of Jinjiang City at a
consideration of RMB13,607,475.17;
(v) a transfer of land use rights agreement dated 15 December 2017 entered into between
Jiujiuwang Food and State-owned Land Resources Bureau of Jinjiang City* (晉江市國
土資源局), pursuant to which Bureau of Land and Resources of Jinjiang City agreed to
transfer the land use rights of a parcel of state-owned land to Jiujiuwang Food;
(w) a construction agreement dated 19 April 2018 entered into between Jiujiuwang Food
and Quanzhou City Huitai Steel Structure Engineering Co., Ltd.* (泉州市匯泰鋼結構工
程有限公司), pursuant to which Quanzhou City Huitai Steel Structure Engineering Co.,
Ltd. shall build a steel structure building at the premises of Jiujiuwang Food;
(x) a construction agreement dated 4 September 2018 entered into between Jiujiuwang Food
and Jinjiang City Xinchangsheng Steel Structure Engineering Co., Ltd.* (晉江市新長盛
鋼結構有限公司), pursuant to which Jinjiang City Xinchangsheng Steel Structure
Engineering Co., Ltd. shall build a steel structure building at the premises of Jiujiuwang
Food;
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-10 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(y) a sewage treatment project agreement dated 14 September 2018 entered into between
Jiujiuwang Food and Quanzhou City Tianlong Environmental Engineering Co., Ltd.*
(泉州市天龍環境工程有限公司), pursuant to which Quanzhou City Tianlong
Environmental Engineering Co., Ltd. shall build a sewage treatment system for
Jiujiuwang Food;
(z) an [REDACTED] dated 5 October 2018 entered into among our Company,
[REDACTED] and our Company’s then existing shareholders, namely Jianeng, Haisen
and Xiejia, pursuant to which, our Company allotted and issued [REDACTED] at a par
value of US$0.10 in our Company to [REDACTED], representing approximately
[REDACTED] of the enlarged issued share capital of our Company at a consideration of
[REDACTED];
(aa) a construction agreement dated 7 January 2019 entered into between Jiujiuwang Food
and Fujian Shengdexing Construction Engineering Co., Ltd.* (福建省得興建設工程有
限公司), pursuant to which Fujian Shengdexing Construction Engineering Co., Ltd.
shall construct an infrastructure project in Integrated Circuit Industrial Park for
Jiujiuwang Food;
(bb) the Deed of Indemnity;
(cc) the Deed of Non-competition; and
(dd) the [REDACTED].
2. Intellectual property rights of our Group
(a) Trademarks
As at the Latest Practicable Date, our Group was the registered proprietor of the
following trademarks which, in the opinion of our Directors, are material to our business:
No. TrademarkRegistration
no. Class
Name ofregisteredproprietor
Place ofregistration Expiry date
1 1457983 30 Jiujiuwang Food PRC 13 October 2020
2 1498043 30 Jiujiuwang Food PRC 27 December 2020
3 3269794 30 Jiujiuwang Food PRC 13 October 2023
4 3889453 30 Jiujiuwang Food PRC 6 December 2025
5 3891076 30 Jiujiuwang Food PRC 6 December 2025
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-11 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
No. TrademarkRegistration
no. Class
Name ofregisteredproprietor
Place ofregistration Expiry date
6 3957053 30 Jiujiuwang Food PRC 27 January 2026
7 3993913 30 Jiujiuwang Food PRC 27 October 2026
8 4261216 30 Jiujiuwang Food PRC 13 February 2027
9 4261217 29 Jiujiuwang Food PRC 13 February 2027
10 4261218 32 Jiujiuwang Food PRC 13 February 2027
11 4267497 30 Jiujiuwang Food PRC 20 February 2027
12 5381932 30 Jiujiuwang Food PRC 20 July 2029
13 5381935 30 Jiujiuwang Food PRC 13 May 2029
14 5561476 32 Jiujiuwang Food PRC 27 June 2029
15 5561477 18 Jiujiuwang Food PRC 27 February 2020
16 5561478 25 Jiujiuwang Food PRC 13 July 2020
17 5561479 28 Jiujiuwang Food PRC 13 October 2029
18 5561480 29 Jiujiuwang Food PRC 27 May 2029
19 5561481 16 Jiujiuwang Food PRC 6 September 2029
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-12 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
No. TrademarkRegistration
no. Class
Name ofregisteredproprietor
Place ofregistration Expiry date
20 5628567 32 Jiujiuwang Food PRC 20 July 2029
21 5628569 32 Jiujiuwang Food PRC 20 July 2029
22 5628572 29 Jiujiuwang Food PRC 6 June 2029
23 5628574 25 Jiujiuwang Food PRC 27 October 2029
24 5628575 18 Jiujiuwang Food PRC 20 October 2029
25 5628577 14 Jiujiuwang Food PRC 20 September 2029
26 5628579 12 Jiujiuwang Food PRC 6 July 2029
27 5628581 5 Jiujiuwang Food PRC 13 November 2029
28 5628585 24 Jiujiuwang Food PRC 13 October 2029
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-13 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
No. TrademarkRegistration
no. Class
Name ofregisteredproprietor
Place ofregistration Expiry date
29 5660052 32 Jiujiuwang Food PRC 27 July 2029
30 5660053 30 Jiujiuwang Food PRC 6 August 2029
31 5660054 29 Jiujiuwang Food PRC 20 October 2029
32 5660055 25 Jiujiuwang Food PRC 20 December 2029
33 5660056 24 Jiujiuwang Food PRC 6 February 2020
34 5660057 18 Jiujiuwang Food PRC 6 November 2029
35 5660058 14 Jiujiuwang Food PRC 27 September 2029
36 5660059 12 Jiujiuwang Food PRC 20 December 2029
37 5675738 42 Jiujiuwang Food PRC 27 October 2029
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-14 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
No. TrademarkRegistration
no. Class
Name ofregisteredproprietor
Place ofregistration Expiry date
38 5675740 35 Jiujiuwang Food PRC 27 October 2029
39 5837153 30 Jiujiuwang Food PRC 6 November 2029
40 5837198 30 Jiujiuwang Food PRC 6 November 2029
41 6088134 5 Jiujiuwang Food PRC 20 July 2024
42 7129493 30 Jiujiuwang Food PRC 20 July 2020
43 8325721 30 Jiujiuwang Food PRC 27 May 2021
44 8325714 30 Jiujiuwang Food PRC 20 May 2022
45 8325701 29 Jiujiuwang Food PRC 27 February 2024
46 8325691 32 Jiujiuwang Food PRC 27 May 2021
47 8760531 10 Jiujiuwang Food PRC 20 November 2021
48 9880259 30 Jiujiuwang Food PRC 27 October 2022
49 9924112 30 Jiujiuwang Food PRC 6 November 2022
50 11052453 30 Jiujiuwang Food PRC 6 April 2025
51 11327857 30 Jiujiuwang Food PRC 13 April 2025
52 12457266 30 Jiujiuwang Food PRC 27 September 2024
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-15 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
No. TrademarkRegistration
no. Class
Name ofregisteredproprietor
Place ofregistration Expiry date
53 14460700 30 Jiujiuwang Food PRC 27 July 2025
54 14577425 30 Jiujiuwang Food PRC 13 May 2026
55 15759626 30 Jiujiuwang Food PRC 13 January 2026
56 15759580 30 Jiujiuwang Food PRC 13 January 2026
57 18026248 30 Jiujiuwang Food PRC 20 January 2027
58 18671937 30 Jiujiuwang Food PRC 27 January 2027
59 18671866 29 Jiujiuwang Food PRC 27 January 2027
60 18671779 38 Jiujiuwang Food PRC 27 January 2027
61 18671717 11 Jiujiuwang Food PRC 27 January 2027
62 18671689 7 Jiujiuwang Food PRC 27 January 2027
63 18671562 2 Jiujiuwang Food PRC 27 January 2027
64 18671451 1 Jiujiuwang Food PRC 27 January 2027
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-16 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
No. TrademarkRegistration
no. Class
Name ofregisteredproprietor
Place ofregistration Expiry date
65 18671426 28 Jiujiuwang Food PRC 27 January 2027
66 18671297 30 Jiujiuwang Food PRC 27 January 2027
67 18671265 29 Jiujiuwang Food PRC 27 January 2027
68 18671102 31 Jiujiuwang Food PRC 27 January 2027
69 18670918 34 Jiujiuwang Food PRC 27 January 2027
70 18670791 40 Jiujiuwang Food PRC 27 January 2027
71 18829643 30 Jiujiuwang Food PRC 13 February 2027
72 18670727 44 Jiujiuwang Food PRC 27 January 2027
73 19309736 30 Jiujiuwang Food PRC 13 January 2028
74 19444944 29 Jiujiuwang Food PRC 27 July 2027
75 20036886 30 Jiujiuwang Food PRC 6 September 2027
76 25072272 32 Jiujiuwang Food PRC 27 June 2028
77 28529733 32 Jiujiuwang Food PRC 13 December 2028
78 25605576 30 Jiujiuwang Food PRC 13 December 2028
79 25073714 30 Jiujiuwang Food PRC 13 September 2028
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-17 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
No. TrademarkRegistration
no. Class
Name ofregisteredproprietor
Place ofregistration Expiry date
80 304788163 30 Jiujiuwang Food Hong Kong 30 December 2028
81 304788172 30 Jiujiuwang Food Hong Kong 30 December 2028
As at the Latest Practicable Date, our Group had applied for the registration of the
following trademarks which, in the opinion of our Directors, are material to our business:
No. TrademarkApplication
no. ClassName ofapplicant
Place ofregistration Application date
1 30274363 32 Jiujiuwang Food PRC 16 April 2018
2 21402256 30 Jiujiuwang Food PRC 23 September 2016
3 33916844 32 Jiujiuwang Food PRC 9 October 2018
4 32688281 32 Jiujiuwang Food PRC 3 August 2018
5 32685605 29 Jiujiuwang Food PRC 3 August 2018
6 32589684 30 Jiujiuwang Food PRC 31 July 2018
7 40543420 30 Jiujiuwang Food PRC 22 August 2019
8 41468664 30 Jiujiuwang Food PRC 8 October 2019
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-18 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
No. TrademarkApplication
no. ClassName ofapplicant
Place ofregistration Application date
9 41492570 30 Jiujiuwang Food PRC 9 October 2019
10 41660121 30 Jiujiuwang Food PRC 16 October 2019
11 41679305 30 Jiujiuwang Food PRC 16 October 2019
(b) Patents
As at the Latest Practicable Date, our Group was the registered proprietor of the
following patents, which, in the opinion of our Directors, are material to our business:
No. Title Patent no. TypePlace ofregistration Expiry date
1 A mould and method of
shaping whistle lollipop
(一種口哨棒棒糖的成型
模具及其成型方法)
ZL201310670705.X Invention PRC 9 December
2033
2 A method of processing
whistle lollipop
(一種口哨泡泡糖的
加工工藝)
ZL201210192813.6 Invention PRC 11 June 2032
3 A candy packaging tube
(一種糖果包裝管 )
ZL201520741292.4 Utility PRC 22 September
2025
4 A new type of tablet candy
packing box
(一種新型糖果片包裝盒)
ZL201320331454.8 Utility PRC 7 June 2023
5 Packaging bag (ice fruit
series) (包裝袋(冰炫
菓子系列))
ZL201630073041.3 Design PRC 14 March 2026
6 Packaging box (refreshing
tablet) ((包裝盒(爽口片))
ZL201330241548.1 Design PRC 7 June 2023
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-19 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(c) Domain names
As at the Latest Practicable Date, our Group was the registered proprietor of the
following domain names which, in the opinion of our Directors, are material to our business:
Domain nameName of registeredproprietor
Date ofregistration Expiry date
www.jiujiuwang.com Jiujiuwang Food 1 April 1999 1 April 2027
www.jiujiuwang.com.cn Jiujiuwang Food 25 May 2005 21 May 2027
(d) Copyrights
As at the Latest Practicable Date, our Group was the registered proprietor of the
following copyrights which, in the opinion of our Directors, are material to our business:
No. TitleRegistrationcertificate no.
Place ofregistration Registration date
1 酷莎一現瞬間來電 (Coolsa
appearing with shocking)
閩作登字-2016-A-
00036396
PRC 21 October 2016
2 清口含片 (Refreshing lozenge) 閩作登字-2014-F-
00013096
PRC 20 August 2014
3 VC酸酸糖 (VC acid candy) 閩作登字-2014-F-
00013092
PRC 20 August 2014
4 無糖爽口片 (Sugar-free
refreshing tablet)
閩作登字-2014-F-
00013097
PRC 20 August 2014
5 拉拉卜口哨酸奶糖 (Lalabo
whistle yogurt candy)
閩作登字-2012-F-
00014946
PRC 25 December 2012
6 拉拉卜口哨泡泡糖西瓜味
(Watermelon flavour Lalabo
whistle bubble gum)
閩作登字-2012-F-
00005373
PRC 10 July 2012
7 拉拉卜口哨泡泡糖香橙味
(Orange flavour Lalabo whistle
bubble gum)
閩作登字-2012-F-
00005372
PRC 10 July 2012
8 拉拉卜口哨泡泡糖草莓味
(Strawberry flavour Lalabo
bubble gum)
閩作登字-2012-F-
00005374
PRC 10 July 2012
9 拉拉卜口哨泡泡哈密瓜味
(Cantaloupe flavour Lalabo
whistle bubble gum)
閩作登字-2012-F-
00005375
PRC 10 July 2012
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-20 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
C. FURTHER INFORMATION ABOUT OUR DIRECTORS AND SUBSTANTIALSHAREHOLDERS
1. Directors
(a) Disclosure of interests — interests and short positions of our Directors and the chiefexecutive of our Company in the shares, underlying shares and debentures of ourCompany and its associated corporations
Immediately following completion of the [REDACTED] and the [REDACTED] and
assuming that the [REDACTED] is not exercised and without taking into account Shares to
be issued and allotted upon the exercise of any options which may be granted under the Share
Option Scheme, the interests or short positions of our Directors or chief executive of our
Company in the shares, underlying shares and debentures of our Company or its associated
corporations (within the meaning of Part XV of the SFO) which will be required to be
notified to our Company and the Stock Exchange pursuant to Divisions 7 and 8 of Part XV of
the SFO (including interests or short positions which they were taken or deemed to have
under such provisions of the SFO) or which will be required, pursuant to section 352 of the
SFO, to be entered in the register referred to therein, or which will be required, pursuant to
the Model Code for Securities Transactions by Directors of Listed Issuers to be notified to
our Company and the Stock Exchange, once our Shares are listed will be as follows:
(i) Interests in our Company
Name Nature of interestInterests in
[REDACTED](1)
Approximatepercentage
shareholding
Mr. Zheng Guosi Interest in a controlled
corporation(2)[REDACTED] (L) [REDACTED]
Interest held jointly with
other persons(3)[REDACTED] (L) [REDACTED]
Mr. Zheng Zhenzhong Interest in a controlled
corporation(4)[REDACTED] (L) [REDACTED]
Interest held jointly with
other persons(3)[REDACTED] (L) [REDACTED]
Notes:
(1) The letter ‘‘L’’ denotes the person’s long position in our Shares.
(2) Xiejia is owned as to 100% by Mr. Zheng Guosi. As such, Mr. Zheng Guosi is deemed to beinterested in the Shares held by Xiejia.
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-21 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(3) On 29 March 2019, Mr. Zheng Zhenzhong, Mr. Zheng Guosi and Mr. Zheng Guodian executedthe Concert Parties Confirmatory Deed to acknowledge and confirm, among other things, thatthey are parties acting in concert (having the meaning as ascribed thereto in the TakeoversCode) in respect of each of the members of our Group since the relevant period, details ofwhich are set out in the section headed ‘‘History, development and Reorganisation — Partiesacting in concert’’ in this document. As such they are deemed to be interested in the Shares heldby each others.
(4) Jianeng is owned as to 100% by Mr. Zheng Zhenzhong. As such, Mr. Zheng Zhenzhong isdeemed to be interested in our Shares held by Jianeng.
(b) Particulars of service contracts
Each of our executive Directors [has entered] into a service contract with our Company
for a term of three years commencing from the [REDACTED], which may be terminated by
not less than three months’ notice in writing served by either party on the other.
Each of the independent non-executive Directors [has signed] a letter of appointment
with our Company for a term of three years with effect from the [REDACTED].
(c) Directors’ remuneration
Each of our executive Directors [has entered] into a service contract with our Company
on [.], is entitled to a director’s fee and shall be paid remuneration on a twelve-month basis.
The aggregate amount of remuneration of our Directors including fees, salaries, discretionary
bonuses, contributions to pension schemes, housing allowances and other allowances and
benefits in kind incurred by our Group for the years ended 31 December 2017, 2018 and
2019 was approximately RMB722,000, RMB717,000 and RMB795,000, respectively.
Each of our independent non-executive Directors [has entered] into a letter of
appointment with our Company on [.] for a term of three years commencing on the
[REDACTED], until terminated by either party giving at least three months notice in writing.
Each independent non-executive Director is entitled to a director’s fee of RMB100,000 per
annum.
Under the arrangement currently in force, the aggregate remuneration (excluding any
discretionary bonus, if any, payable to our Directors) of our Directors for the year ending 31
December 2019 is estimated to be approximately RMB808,000.
Further details of the terms of the abovementioned service contracts are set out in the
paragraph headed ‘‘C. Further information about our Directors and Substantial Shareholders
— 1. Directors — (b) Particulars of service contracts’’ in this section.
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-22 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
2. Substantial Shareholders
So far as is known to our Directors as at the Latest Practicable Date, immediately followingthe completion of the [REDACTED] and the [REDACTED] assuming that the [REDACTED] is notexercised and taking no account of any Shares that may be issued pursuant to the exercise ofoptions which may be granted under the Share Option Scheme, the following persons (other thanour Directors and chief executive of our Company) would have or be deemed or taken to have aninterest and/or short position in our Shares or the underlying Shares which would fall to bedisclosed under the provisions of Division 2 and 3 of Part XV of the SFO:
Shares held immediately after completionof the [REDACTED] (without taking into
account Shares which may be issuedpursuant to the exercise of the
[REDACTED] or Shares which may beissued upon the exercise of options granted
under the Share Option Scheme)
Name ofShareholders Nature of Interest
Number ofShares(1) held/interested in
Percentage ofshareholding in our
Company
Xiejia Beneficial owner [REDACTED] (L) [REDACTED]
Ms. Wu Zihong Interest of spouse(3) [REDACTED] (L) [REDACTED]
Haisen Beneficial owner [REDACTED] (L) [REDACTED]
Mr. Zheng Guodian Interest in a controlledcorporation(4)/Interest heldjointly with otherpersons(2)
[REDACTED] (L) [REDACTED]
Ms. Hong Mali Interest of spouse(5) [REDACTED] (L) [REDACTED]
Jianeng Beneficial owner [REDACTED] (L) [REDACTED]
Ms. Su Li Interest of spouse(6) [REDACTED] (L) [REDACTED]
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-23 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
Notes:
(1) The letter ‘‘L’’ denotes the person’s long position in our Shares.
(2) On 29 March 2019, Mr. Zheng Zhenzhong, Mr. Zheng Guosi and Mr. Zheng Guodian executed the ConcertParties Confirmatory Deed to acknowledge and confirm, among other things, that they are parties acting inconcert in respect of each of the members of our Group since the relevant periods, details of which are set outin the section headed ‘‘History, development and Reorganisation — Parties acting in concert’’ in thisdocument. As such Mr. Zheng Guodian is deemed to be interested in the Shares held by each others.
(3) Ms. Wu Zihong is the spouse of Mr. Zheng Guosi. Under the SFO, Ms. Wu Zihong is deemed to be interestedin the Shares that Mr. Zheng Guosi is interested in.
(4) Haisen is owned as to 100% by Mr. Zheng Guodian. As such, Mr. Zheng Guodian is deemed to be interestedin the Shares held by Haisen.
(5) Ms. Hong Mali is the spouse of Mr. Zheng Guodian. Under the SFO, Ms. Hong Mali is deemed to beinterested in the Shares that Mr. Zheng Guodian is interested in.
(6) Ms. Su Li is the spouse of Mr. Zheng Zhenzhong. Under the SFO, Ms. Su Li is deemed to be interested in allShares that Mr. Zheng Zhenzhong is interested in.
3. Agency fees or commissions received
Save as disclosed in this document, no commissions, discounts, brokerages or other special
terms were granted in connection with the issue or sale of any capital of any member of our Group
within the two years preceding the date of this document.
4. Disclaimers
Save as disclosed herein:
(a) none of our Directors or chief executive of our Company has any interest or short
position in our shares, underlying shares or debentures of our Company or any of its
associated corporation (within the meaning of the SFO) which will have to be notified
to our Company and the Stock Exchange pursuant to Division 7 and 8 of Part XV of the
SFO or which will be required, pursuant to section 352 of the SFO, to be entered in the
register referred to therein, or which will be required to be notified to our Company and
the Stock Exchange pursuant to the Model Code for Securities Transactions by
Directors of Listed Issuers once our Shares are listed;
(b) none of our Directors or experts referred to under the paragraph headed ‘‘D. Other
information — 8. Qualification of experts’’ in this appendix has any direct or indirect
interest in the promotion of our Company, or in any assets which have within the two
years immediately preceding the date of this document been acquired or disposed of by
or leased to any member of our Group;
(c) none of our Directors is materially interested in any contract or arrangement subsisting
at the date of this document which is significant in relation to the business of our Group
taken as a whole;
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-24 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(d) none of our Directors has any existing or proposed service contracts with any member
of our Group (excluding contracts expiring or determinable by the employer within one
year without payment of compensation (other than statutory compensation));
(e) taking no account of Shares which may be taken up under the [REDACTED], none of
our Directors knows of any person (not being a Director or chief executive of our
Company) who will, immediately following completion of the [REDACTED], have an
interest or short position in our Shares or underlying Shares of our Company which
would fall to be disclosed to our Company under the provisions of Divisions 2 and 3 of
Part XV of SFO or be interested, Directly or indirectly, in 10% or more of issued voting
shares of any member of our Group;
(f) none of the experts referred to under the paragraph headed ‘‘D. Other information — 8.
Qualification of experts’’ in this appendix has any shareholding in any member of our
Group or the right (whether legally enforceable or not) to subscribe for or to nominate
persons to subscribe for securities in any member of our Group; and
(g) so far as is known to our Directors as at the Latest Practicable Date, none of our
Directors, their respective close associates (as defined under the Listing Rules) or
Shareholders of our Company who are interested in more than 5% of the number of
issued Shares has any interests in the five largest customers or the five largest suppliers
of our Group.
D. OTHER INFORMATION
1. Share Option Scheme
The following is a summary of the principal terms of the Share Option Scheme conditionally
adopted by the written resolutions of our Shareholders passed on [.]. The terms of the Share
Option Scheme are in compliance with the provisions of Chapter 17 of the Listing Rules.
(a) Purpose
The Share Option Scheme is a share incentive scheme and is established to recognise
and acknowledge the contributions the Eligible Participants (as defined in paragraph (b)
below) have had or may have made to our Group. The Share Option Scheme will provide the
Eligible Participants an opportunity to have a personal stake in our Company with the view to
achieving the following objectives:
(i) motivating the Eligible Participants to optimise their performance efficiency for
the benefit of our Group; and
(ii) attracting and retaining or otherwise maintaining on-going business relationships
with the Eligible Participants whose contributions are or will be beneficial to the
long term growth of our Group.
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-25 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(b) Who may join
The Board may, at its discretion, offer to grant an option to subscribe for such number
of new Shares as the Board may determine at an exercise price determined in accordance
with paragraph (f) below to the following persons (‘‘Eligible Participants’’):
(i) any full-time or part-time employees, executives or officers of our Company or
any of its subsidiaries;
(ii) any Directors (including independent non-executive Directors) of our Company or
any of its subsidiaries;
(iii) any advisers, consultants, suppliers, customers and agents to our Company or any
of its subsidiaries; and
(iv) such other persons who, in the sole opinion of the Board, will contribute or have
contributed to our Group, the assessment criteria of which are:
(aa) contribution to the development and performance of our Group;
(bb) quality of work performed for our Group;
(cc) initiative and commitment in performing his duties; and
(dd) length of service or contribution to our Group.
(c) Acceptance of an offer of options
An option shall be deemed to have been granted and accepted by the grantee and to
have taken effect when the duplicate offer document constituting acceptance of the options
duly signed by the grantee, together with a remittance in favour of our Company of HK$1.00
by way of consideration for the grant thereof, is received by our Company on or before the
relevant acceptance date. Such payment shall in no circumstances be refundable. Any offer
for grant of an option to subscribe for Shares may be accepted in respect of less than the
number of Shares for which it is offered provided that it is accepted in respect of a board lot
for dealing in Shares on the Stock Exchange or an integral multiple thereof and such number
is clearly stated in the duplicate offer document constituting acceptance of the option. To the
extent that the offer to grant an option is not accepted by any prescribed acceptance date, it
shall be deemed to have been irrevocably declined.
Subject to paragraphs (l), (m), (n), (o) and (p), an option shall be exercised in whole or
in part and, other than where it is exercised to the full extent outstanding, shall be exercised
in integral multiples of such number of Shares as shall represent one board lot for dealing in
Shares on the Stock Exchange for the time being, by the grantee by giving notice in writing
to our Company stating that the option is thereby exercised and the number of Shares in
respect of which it is exercised. Each such notice must be accompanied by a remittance for
the full amount of the exercise price for the Shares in respect of which the notice is given.
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-26 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
Within 21 days after receipt of the notice and the remittance and, where appropriate,
receipt of the certificate by the auditors to our Company or the independent financial adviser
as the case may be pursuant to paragraph (r), our Company shall allot and issue the relevant
number of Shares to the grantee credited as fully paid and issue to the grantee share
certificates in respect of the Shares so allotted.
The exercise of any option shall be subject to our Shareholders in general meeting
approving any necessary increase in the authorised share capital of our Company.
(d) Maximum number of shares
The maximum number of Shares which may be issued upon exercise of all option to be
granted (including Shares in respect of which options, whether exercised or still outstanding,
have already been granted) under the Share Option Scheme and under any other share option
schemes of our Company must not in aggregate exceed 10% of the total number of Shares in
issue on the [REDACTED] (but taking account of any Shares which may be issued under the
exercise of the [REDACTED]), being [REDACTED] (the ‘‘Scheme Limit’’), excluding for
this purpose Shares which would have been issuable pursuant to options which have lapsed in
accordance with the terms of the Share Option Scheme (or any other share option schemes of
our Company). Subject to the issue of a circular by our Company and the approval of our
Shareholders in general meeting and/or such other requirements prescribed under the Listing
Rules from time to time, the Board may:
(i) renew this limit at any time to 10% of the Shares in issue (the ‘‘New SchemeLimit’’) as at the date of the approval by our Shareholders in general meeting;
and/or
(ii) grant options beyond the Scheme Limit to Eligible Participants specifically
identified by the Board. The circular issued by our Company to our Shareholders
shall contain a generic description of the specified Eligible Participants who may
be granted such options, the number and terms of the options to be granted, the
purpose of granting options to the specified Eligible Participants with an
explanation as to how the options serve such purpose, the information required
under Rule 17.02(2)(d) and the disclaimer required under Rule 17.02(4) of the
Listing Rules.
Notwithstanding the foregoing, the Shares which may be issued upon exercise of all
outstanding options granted and yet to be exercised under the Share Option Scheme and any
other share option schemes of our Company at any time shall not exceed 30% of the Shares
in issue from time to time (the ‘‘Maximum Limit’’). No options shall be granted under any
schemes of our Company (including the Share Option Scheme) if this will result in the
Maximum Limit being exceeded. The maximum number of Shares in respect of which options
may be granted shall be adjusted, in such manner as the auditors of our Company or an
approved independent financial adviser shall certify to be appropriate, fair and reasonable in
the event of any alteration in the capital structure of our Company in accordance with
paragraph (r) below whether by way of capitalisation issue, rights issue, consolidation, sub-
division of shares or reduction of the share capital of our Company but in no event shall
exceed the limit prescribed in this paragraph.
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-27 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(e) Maximum number of options to any one individual
The total number of Shares issued and which may fall to be issued upon exercise of the
options granted under the Share Option Scheme and any other share option schemes of our
Company (including both exercised, outstanding options and Shares which were the subject
of options which have been granted and accepted under the Share Option Scheme or any
other scheme of our Company but subsequently cancelled (the ‘‘Cancelled Shares’’) to each
Eligible Participant in any 12-month period up to the date of grant shall not exceed 1% of the
Shares in issue as at the date of grant. Any further grant of options in excess of this 1% limit
shall be subject to:
(i) the issue of a circular by our Company containing the identity of the Eligible
Participant, the numbers of and terms of the options to be granted (and options
previously granted to such participant) the information as required under Rule
17.02(2)(d) and the disclaimer required under Rule 17.02(4) of the Listing Rules;
and
(ii) the approval of our Shareholders in general meeting and/or other requirements
prescribed under the Listing Rules from time to time with such Eligible
Participant and his close associates (as defined in the Listing Rules) (or his/her
associates if the participant is a connected person) abstaining from voting. The
numbers and terms (including the exercise price) of options to be granted to such
participant must be fixed before our Shareholders’ approval and the date of the
Board meeting at which the Board proposes to grant the options to such Eligible
Participant shall be taken as the date of grant for the purpose of calculating the
subscription price of the Shares. The Board shall forward to such Eligible
Participant an offer document in such form as the Board may from time to time
determine or, alternatively, documents accompanying the offer document which
state, among other things:
(aa) the Eligible Participant’s name, address and occupation;
(bb) the date on which an option is offered to an Eligible Participant which must
be a date on which the Stock Exchange is open for the business of dealing in
securities;
(cc) the date upon which an offer for an option must be accepted;
(dd) the date upon which an option is deemed to be granted and accepted in
accordance with paragraph (c);
(ee) the number of Shares in respect of which the option is offered;
(ff) the subscription price and the manner of payment of such price for the
Shares on and in consequence of the exercise of the option;
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-28 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(gg) the date of the notice given by the grantee in respect of the exercise of the
option; and
(hh) the method of acceptance of the option which shall, unless the Board
otherwise determines, be as set out in paragraph (c).
(f) Price of shares
The subscription price of a Share in respect of any particular option granted under the
Share Option Scheme shall be such price as the Board in its absolute discretion shall
determine, save that such price will not be less than the highest of:
(i) the closing price of the Shares as stated in the Stock Exchange’s daily quotations
sheet on the date of grant, which must be a day on which the Stock Exchange is
open for the business of dealing in securities;
(ii) the average closing price of the Shares as stated in the Stock Exchange’s daily
quotations sheets for the five business days immediately preceding the date of
grant; and
(iii) the nominal value of a Share.
(g) Granting options to connected persons
Any grant of options to a Director, chief executive or substantial shareholder (as
defined in the Listing Rules) of our Company or any of their respective associates (as defined
in the Listing Rules) is required to be approved by the independent non-executive Directors
(excluding any independent non-executive Director who is the grantee of the options). If the
Board proposes to grant options to a substantial shareholder or any independent non-
executive Director or their respective associates (as defined in the Listing Rules) which will
result in the number of Shares issued and to be issued upon exercise of options granted and
to be granted (including options exercised, cancelled and outstanding) such person in the 12-
month period up to and including the date of such grant:
(i) representing in aggregate over 0.1% of the Shares in issue; and
(ii) having an aggregate value in excess of HK$5 million or such other sum as may be
from time to time provided under the Listing Rules, based on the closing price of
the Shares as stated in the daily quotations sheet of the Stock Exchange at the date
of each grant,
such further grant of options will be subject to the approval of our independent non-executive
Directors as referred to in this paragraph, the issue of a circular by our Company and the
approval of our Shareholders in general meeting on a poll at which the grantee, his associates
and all core connected persons (as defined in the Listing Rules) of our Company shall abstain
from voting in favour, and/or such other requirements prescribed under the Listing Rules
from time to time. Any vote taken at the meeting to approve the grant of such options shall
be taken as a poll.
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-29 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
The circular to be issued by our Company to our Shareholders pursuant to the above
paragraph shall contain the following information:
(i) the details of the number and terms (including the exercise price) of the options to
be granted to each selected Eligible Participant, which must be fixed before our
Shareholders’ meeting and the date of the Board meeting for proposing such
further grant shall be taken as the date of grant for the purpose of calculating the
exercise price of such options;
(ii) a recommendation from our independent non-executive Directors (excluding any
independent non-executive Director who is the grantee of the options) to the
independent Shareholders as to voting;
(iii) the information required under Rule 17.02(2)(c) and (d) and the disclaimer
required under Rule 17.02(4) of the Listing Rules; and
(iv) the information required under Rule 2.17 of the Listing Rules.
(h) Restrictions on the times of grant of options
A grant of options may not be made after inside information has come to our
Company’s knowledge until such information has been announced pursuant to the
requirements of the Listing Rules and the Inside Information Provisions of Part XIVA of the
SFO. In particular, no options may be granted during the period commencing one month
immediately preceding the earlier of:
(i) the date of the Board meeting (such date to first be notified to the Stock Exchange
in accordance with the Listing Rules) for the approval of our Company’s results
for any year, half-year, quarterly or any other interim period (whether or not
required under the Listing Rules); and
(ii) the deadline for our Company to publish an announcement of the results for any
year, or half-year, or quarterly or any other interim period (whether or not
required under the Listing Rules);
and ending on the date of actual publication of the results announcement.
(i) Rights are personal to grantee
An option is personal to the grantee. No grantee shall in any way sell, transfer, assign,
charge, mortgage, encumber or otherwise dispose of or create any interest whatsoever in
favour of any third party over or in relation to any option or attempt so to do (save that the
grantee may nominate a nominee in whose name the Shares issued pursuant to the Share
Option Scheme may be registered). Any breach of the foregoing by a grantee shall entitle our
Company to cancel any outstanding options or any part thereof granted to such grantee.
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-30 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(j) Time of exercise of option and duration of the share option scheme
An option may be exercised in accordance with the terms of the Share Option Scheme
at any time after the date upon which the option is deemed to be granted and accepted and
prior to the expiry of ten years from that date. The minimum period for which an option must
be held before it can be exercised will be determined by the Board in its absolute discretion,
save that no option may be exercised more than ten years after it has been granted. No option
may be granted more than 10 years after the date of approval of the Share Option Scheme by
the Shareholders of our Company (the ‘‘Adoption Date’’). Subject to earlier termination by
our Company in general meeting or by the Board, the Share Option Scheme shall be valid
and effective for a period of 10 years from the Adoption Date.
(k) Performance target
A grantee may be required to achieve any performance targets as the Board may then
specify in the grant before any options granted under the Share Option Scheme can be
exercised.
(l) Rights on ceasing employment/death
If the grantee of an option ceases to be an Eligible Participant:
(i) by any reason other than death, ill-health, injury, disability or termination of his/
her relationship with our Company and/or any of its subsidiaries on one or more
of the grounds specified in paragraph (m) below, the grantee may exercise the
option up to the entitlement of the grantee as at the date of cessation (to the extent
not already exercised) in whole or in part within a period of one month (or such
longer period as the Board may determine) from such cessation which date shall
be the last actual working day with our Company or the relevant subsidiary
whether salary is paid in lieu of notice or not, failing which it will lapse (or such
longer period as our Company may determine); or
(ii) by reason of death, ill-health, injury or disability (all evidenced to the satisfaction
of the Board) and none of the events which would be a ground for termination of
his relationship with our Company and/or any of its subsidiaries under paragraph
(m) has occurred, the grantee or, as appropriate, his personal representative(s) may
exercise the option in full (to the extent not already exercised) within a period of
12 months (or such longer period as the Board may determine) from the date of
cessation of being an Eligible Participant or death.
(m) Rights on dismissal
If the grantee of an option ceases to be an Eligible Participant on the grounds that he
has been guilty of serious misconduct, or has committed any act of bankruptcy or has become
insolvent or has made any arrangements or composition with his/her creditors generally, or
has been convicted of any criminal offence involving his/her integrity or honesty, his/her
option will lapse and not be exercisable after the date of termination of his/her employment.
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-31 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(n) Rights on takeover
If a general offer is made to all our Shareholders (or all such Shareholders other than
the offeror and/or any person controlled by the offeror and/or any person acting in concert
with the offeror (as defined in the Takeovers Code)) and such offer becomes or is declared
unconditional during the option period of the relevant option, the grantee of an option shall
be entitled to exercise the option in full (to the extent not already exercised) at any time
within 14 days after the date on which the offer becomes or is declared unconditional.
(o) Rights on winding-up
In the event that a notice is given by our Company to its members to convene a general
meeting for the purposes of considering, and if thought fit, approving a resolution to
voluntarily wind-up our Company, our Company shall forthwith give notice thereof to all
grantees and thereupon, each grantee (or his legal personal representative(s)) shall be entitled
to exercise all or any of his options (to the extent not already exercised) at any time not later
than two business days prior to the proposed general meeting of our Company referred to
above by giving notice in writing to our Company, accompanied by a remittance for the full
amount of the aggregate subscription price for the Shares in respect of which the notice is
given, whereupon our Company shall as soon as possible and, in any event, no later than the
business day immediately prior to the date of the proposed general meeting, allot the relevant
Shares to the grantee credited as fully paid.
(p) Rights on compromise or arrangement between our company and its members or
creditors
If a compromise or arrangement between our Company and its members or creditors is
proposed for the purposes of a scheme for the reconstruction of our Company or its
amalgamation with any other companies pursuant to the laws of the jurisdiction in which our
Company was incorporated, our Company shall give notice to all the grantees of the options
on the same day as it gives notice of the meeting to its members or creditors summoning the
meeting to consider such a compromise or arrangement and any grantee may by notice in
writing to our Company accompanied by a remittance for the full amount of the aggregate
subscription price for our Shares in respect of which the notice is given (such notice to be
received by our Company no later than two business days prior to the proposed meeting),
exercise the option to its full extent or to the extent specified in the notice and our Company
shall as soon as possible and in any event no later than the business day immediately prior to
the date of the proposed meeting, allot and issue such number of Shares to the grantee which
falls to be issued on such exercise of the option credited as fully paid and register the grantee
as holder thereof.
With effect from the date of such meeting, the rights of all grantees to exercise their
respective options shall forthwith be suspended. Upon such compromise or arrangement
becoming effective, all options shall, to the extent that they have not been exercised, lapse
and determine. If for any reason such compromise or arrangement does not become effective
and is terminated or lapses, the rights of grantees to exercise their respective options shall
with effect from such termination be restored in full but only upon the extent not already
exercised and shall become exercisable.
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-32 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(q) Ranking of shares
Our Shares to be allotted upon the exercise of an option will not carry voting rights
until completion of the registration of the grantee (or any other person) as the holder thereof.
Subject to the aforesaid, Shares allotted and issued on the exercise of options will rank pari
passu and shall have the same voting, dividend, transfer and other rights (including those
arising on liquidation) as at attached to the other fully-paid Shares in issue on the date of
exercise, save that they will not rank for any dividend or other distribution declared or
recommended or resolved to be paid or made by reference to a record date falling on or
before the date of exercise.
(r) Effect of alterations to capital
In the event of any alteration in the capital structure of our Company whilst any option
may become or remains exercisable, whether by way of capitalisation issue, rights issue,
consolidation, subdivision or reduction of share capital of our Company, such corresponding
alterations (if any) shall be made in the number of Shares subject to any outstanding options
and/or the subscription price per Share of each outstanding option as the auditors of our
Company or an independent financial adviser shall certify in writing to the Board to be in
their/his opinion fair and reasonable in compliance with Rule 17.03(13) of the Listing Rules
and the note thereto and the supplementary guidance attached to the letter from the Stock
Exchange dated 5 September 2005 to all issuers relating to share option schemes. The
capacity of the auditors of our Company or the approved independent financial adviser, as the
case may be, in this paragraph is that of experts and not arbitrators and their certificate shall,
in the absence of manifest error, be final and conclusive and binding on our Company and the
grantees.
Any such alterations will be made on the basis that a grantee shall have the same
proportion of the equity capital of our Company (as interpreted in accordance with the
supplementary guidance attached to the letter from the Stock Exchange dated 5 September
2005 to all issuers relating to share option schemes) for which any grantee of an option is
entitled to subscribe pursuant to the options held by him before such alteration provided that
no such alteration shall be made if the effect of which would be to enable a Share to be
issued at less than its nominal value. The issue of securities as consideration in a transaction
is not to be regarded as a circumstance requiring any such alterations.
(s) Expiry of option
An option shall lapse automatically and shall not be exercisable (to the extent not
already exercised) on the earliest of:
(i) the date of expiry of the option as may be determined by the Board;
(ii) the expiry of any of the periods referred to in paragraphs (l), (m), (n); or
(iii) the date upon which the scheme of arrangement of our Company referred to in
paragraph (p) becomes effective;
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-33 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(iv) subject to paragraph (o), the date of commencement of the winding-up of our
Company;
(v) the date upon which the grantee ceases to be an Eligible Participant by reason of
such grantee’s resignation from the employment of our Company or any of its
subsidiaries or the termination of his or her employment or contract on the
grounds that he or she has been guilty of serious misconduct, or has committed
any act of bankruptcy or is unable to pay his or her debts or has become insolvent
or has made any arrangement or has compromised with his or her creditors
generally, or has been convicted of any criminal offence involving his or her
integrity or honesty or has been in breach of contract. A resolution of the Board to
the effect that the employment of a grantee has or has not been terminated on one
or more of the grounds specified in this paragraph shall be conclusive; or
(vi) the date upon which the Board shall exercise our Company’s right to cancel the
option at any time after the grantee commits a breach of paragraph (i) above or the
options are cancelled in accordance with paragraph (u) below.
(t) Alteration of the Share Option Scheme
The Share Option Scheme may be altered in any respect by resolution of the Board
except that:
(i) any alteration to the advantage of the grantees or the Eligible Participants (as the
case may be) in respect of the matters contained in Rule 17.03 of the Listing
Rules; and
(ii) any material alteration to the terms and conditions of the Share Option Scheme or
any change to the terms of options granted, shall first be approved by our
Shareholders in general meeting provided that if the proposed alteration shall
adversely affect any option granted or agreed to be granted prior to the date of
alteration, such alteration shall be further subject to the grantees’ approval in
accordance with the terms of the Share Option Scheme. The amended terms and
any adjustment to be made to the exercise price of the Share Option Scheme shall
still comply with Chapter 17 of the Listing Rules, the supplemental guidance of 5
September 2005 and any future guidance or interpretation of the Listing Rules
from time to time and any change to the authority of the Board in relation to any
alteration to the terms of the Share Option Scheme must be approved by the
Shareholders in general meeting.
(u) Cancellation of options
Any cancellation of options granted but not exercised must be approved by the grantees
of the relevant options in writing. For the avoidance of doubt, such approval is not required
in the event that any option is cancelled pursuant to paragraph (i) above.
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-34 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(v) Termination of the Share Option Scheme
Our Company may by resolution in general meeting or the Board may at any time
terminate the Share Option Scheme and in such event no further option shall be offered but
the provisions of the Share Option Scheme shall remain in force to the extent necessary to
give effect to the exercise of any option granted prior thereto or otherwise as may be required
in accordance with the provisions of the Share Option Scheme.
Options granted prior to such termination but not yet exercised at the time of
termination shall continue to be valid and exercisable in accordance with the Share Option
Scheme.
(w) Administration of the Board
The Share Option Scheme shall be subject to the administration of the Board whose
decision as to all matters arising in relation to the Share Option Scheme or its interpretation
or effect (save as otherwise provided herein) shall be final and binding on all parties.
(x) Conditions of the Share Option Scheme
The Share Option Scheme is conditional on:
(i) the [REDACTED] granting the [REDACTED] of and [REDACTED] in, on the
Main Board of the [REDACTED], our [REDACTED] which may fall to be issued
pursuant to the exercise of options to be granted under the Share Option Scheme;
(ii) the obligations of the [REDACTED] under the [REDACTED] becoming
unconditional (including, if relevant, as a result of the waiver of any such
condition(s) by the [REDACTED] (for themselves and on behalf of the
[REDACTED])) and not being terminated in accordance with the terms of the
[REDACTED] or otherwise; and
(iii) the commencement of dealings in our Shares on the Stock Exchange.
If the conditions in paragraph (x) above are not satisfied within 12 calendar months
from the Adoption Date:
(i) the Share Option Scheme shall forthwith determine;
(ii) any option granted or agreed to be granted pursuant to the Share Option Scheme
and any offer of such a grant shall be of no effect; and
(iii) no person shall be entitled to any rights or benefits or be under any obligations
under or in respect of the Share Option Scheme or any option granted thereunder.
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-35 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(y) Disclosure in annual and interim reports
Our Company will disclose details of the Share Option Scheme in its annual and interim
reports including the number of options, date of grant, exercise price, exercise period and
vesting period during the financial year/period in the annual/interim reports in accordance
with the Listing Rules in force from time to time.
As at the Latest Practicable Date, no option had been granted or agreed to be granted
under the Share Option Scheme.
Application has been made to the [REDACTED] for the [REDACTED] of, and
[REDACTED] in, the [REDACTED] which may fall to be issued pursuant to the exercise of
the options to be granted under the Share Option Scheme, being [REDACTED] in total.
2. Tax and other indemnities
On [.], our Controlling Shareholders (the ‘‘Indemnifiers’’) entered into the Deed of
Indemnity in favour of our Company (for itself and as trustee for each of its subsidiaries stated
therein), to provide indemnities on a joint and several basis, in respect of, among other matters:
(a) any liability for Hong Kong estate duty which might be incurred by any member of our
Group by reason of any transfer of property (within the meaning of sections 35 and 43
of the Estate Duty Ordinance (Chapter 111 of the Laws of Hong Kong) or the
equivalent thereof under the laws of any jurisdiction outside Hong Kong) to any
member of our Group at any time on or before the [REDACTED];
(b) tax liabilities (including all fines, penalties, costs, charges, expenses and interests
incidental or relating to taxation) which might be payable by any member of our Group
in respect of any income, profits, gains, transactions, events, matters or things earned,
accrued, received, entered into or occurring on or before the [REDACTED], whether
alone or in conjunction with any other circumstances whenever occurring and whether
or not such tax liabilities are chargeable against or attributable to any other person,
firm, company or corporation;
(c) any expenses, payments, sums, outgoings, fees, demands, claims, damages, losses, costs
(including but not limited to legal and other professional costs), charges, liabilities,
fines, penalties in connection with any failure, delay or defects of corporate or
regulatory compliance or errors, discrepancies or missing documents in the statutory
records of any member of our Group under, or any breach of any provision of, the
Companies Ordinance or any other applicable laws, rules or regulations on or before the
date on which the [REDACTED] becomes unconditional;
(d) all claims, actions, losses, damages, costs or expenses suffered or incurred by any of the
members of our Group in connection with the social insurance and housing provident
fund contributions required to be made by the relevant laws and regulations in the PRC,
which any member of our Group has failed to make in accordance with such laws and
regulations from their respective date of establishment to the [REDACTED]; and
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-36 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(e) all claims, payments, suits, damages, settlements, sums, outgoings, fees, losses and any
associated costs and expenses which would be incurred or suffered directly or
indirectly, from or on the basis of or in connection with the legal proceedings and non-
compliance matters by any member of our Group as described in the sections headed
‘‘Business — Legal proceedings and compliance’’ and ‘‘Business — Licences, permits
and approvals’’ in this document or in connection with any other non-compliance of any
member of our Group which has occurred at any time on or before the [REDACTED].
Each Indemnifier is under no liability under the Deed of Indemnity in respect of any taxation:
(a) to the extent that provision or reserve has been made for such taxation in the audited
accounts of any member of our Group for any accounting period up to 31 December
2019;
(b) to the extent that such taxation or liability falling on any of the members of our Group
in respect of any accounting period commencing on or after 1 June 2019 and ending on
the [REDACTED], where such taxation or liability would not have arisen but for some
act or omission of, or transaction voluntarily entered into by, any member of our Group
(whether alone or in conjunction with some other act, omission or transaction, whenever
occurring) without the prior written consent or agreement of the Indemnifier, other than
any such act, omission or transaction:
(i) carried out or effected in the ordinary course of business or in the ordinary course
of acquiring and disposing of capital assets on or before the [REDACTED]; and
(ii) carried out, made or entered into pursuant to a legally binding commitment
created on or before the [REDACTED] or pursuant to any statement of intention
made in this document; or
(c) to the extent that such taxation liabilities or claim arise or are incurred as a result of the
imposition of taxation as a consequence of any retrospective change in the law, rules
and regulations or the interpretation or practice thereof by the Inland Revenue
Department of Hong Kong or the taxation authority of the PRC, or any other relevant
authority (whether in Hong Kong or the PRC or any other part of the world) coming
into force after the date of the Deed of Indemnity or to the extent such claim arises or is
increased by an increase in rates of taxation or claim after the date of the Deed of
Indemnity with retrospective effect; or
(d) to the extent that any provision or reserve made for taxation in the audited accounts of
any member of our Group up to 31 December 2019 which is finally established to be an
over-provision or an excessive reserve, in which case the Indemnifiers’ liability (if any)
in respect of taxation shall be reduced by an amount not exceeding such provision or
reserve, provided that the amount of any such provision or reserve applied referred to in
this paragraph to reduce the Indemnifiers’ liability in respect of taxation shall not be
available in respect of any such liability arising thereafter.
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-37 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
Our Controlling Shareholders have entered into the Deed of Indemnity in favour of us to
provide, inter alia, indemnities on a joint and several basis in respect of, among other matters, any
costs, expenses, claims, liabilities, penalties, losses or damages incurred or suffered by any
member of our Group arising from or in connection with any defective title relating to certain
properties, and any litigation, arbitration, claims or administrative proceedings, whether of
administrative, contractual, tortuous or otherwise nature instituted by or against any member of our
Group in relation to events occurred on or before the [REDACTED].
Under the Deed of Indemnity, each Indemnifier has also undertaken to us that it will
indemnify and at all times keeps us fully indemnified, on a joint and several basis, from any
depletion in or reduction in value of its assets or any loss (including all legal costs and suspension
of operation), cost, expenses, damages or other liabilities which any member of our Group may
incur or suffer arising from or in connection with the implementation of the Reorganisation.
3. Litigation
As at the Latest Practicable Date, save as disclosed in this document, no member of our
Group was engaged in any litigation or arbitration of material importance and, so far as our
Directors are aware, no litigation or claim of material importance is pending or threatened by or
against any member of our Group.
4. Sole Sponsor
The Sole Sponsor has made an application on our behalf to the Stock Exchange for the
[REDACTED] of, and [REDACTED] in, the Shares in issue and to be issued as mentioned in this
document (including any Shares which may be issued upon the exercise of the [REDACTED] or
options which may be granted under the Share Option Scheme).
The Sole Sponsor satisfies the independence criteria applicable to sponsors as set out in Rule
3A.07 of the Listing Rules.
The Sole Sponsor’s fee in connection with the [REDACTED] is HK$7.5 million.
5. Preliminary expenses
The estimated preliminary expenses incurred and paid by our Company were approximately
RMB21,000.
6. Promoter
Our Company has no promoter for the purposes of the Listing Rules.
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-38 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
7. Taxation of holders of Shares
(a) Hong Kong
The sale, purchase and transfer of Shares registered with our Company’s Hong Kong
branch register of members will be subject to Hong Kong stamp duty, the current rate
charged on each of the purchaser and seller is 0.1% of the consideration of, if higher, of the
fair value of our Shares being sold or transferred. Profits from dealings in our Shares arising
in or derived from Hong Kong may also be subject to Hong Kong profits tax. Our Directors
have been advised that no material liability for estate duty under the laws of China or Hong
Kong would be likely to fall upon any member of our Group.
(b) Cayman Islands
Under the present Cayman Islands law, there is no stamp duty payable in the Cayman
Islands on transfers of shares of Cayman Islands companies except those which hold interests
in land in Cayman Islands.
(c) Consultation with professional advisors
Intending holders of our Shares are recommended to consult their professional advisors
if they are in doubt as to the taxation implications of subscribing for, purchasing, holding or
disposing of or dealing in our Shares or exercising any rights attaching to them. It is
emphasised that none of our Company, our Directors or the other parties involved in the
[REDACTED] can accept responsibility for any tax effect on, or liabilities of, holders of
Shares resulting from their subscription for, purchase, holding or disposal of or dealing in
Shares or exercise of any rights attaching to them.
8. Qualification of experts
The following are the qualifications of the experts who have given their opinion or advicewhich are contained in, or referred to in this document:
Name Qualifications
Lego Corporate Finance Limited Licenced to conduct type 6 (advising on corporatefinance) regulated activity as defined under the SFO
Ogier Legal advisers as to Cayman Islands law
HLB Hodgson Impey ChengLimited
Certified Public Accountants
Fieldfisher Beijing Law Firm Joint legal advisers as to PRC laws
AllBright Law Offices Joint legal advisers as to PRC laws
Frost & Sullivan (Beijing) Inc.,Shanghai Branch Co.
Industry consultants
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-39 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
Name Qualifications
Hogan Lovells Legal advisers as to the applicability of sanctionsadministered by OFAC as well as the laws of othercountries and under international law, including theU.S., the EU, the United Nations and Australia on ourGroup’s sales products to customers in certaincountries during the Track Record Period
Colliers International (Hong Kong)Limited
Property valuer
9. Consents of experts
Each of the experts named in paragraph 8 above has given and has not withdrawn its writtenconsent to the issue of this document with the inclusion of its report and/or letter and/or valuationcertificate and/or opinion and/or the references to its name included herein in the form and contextin which it is respectively included.
10. Interests of experts in our Company
As at the Latest Practicable Date, none of the persons named in paragraph 8 above isinterested beneficially or otherwise in any Shares or shares of any member of our Group or has anyright or option (whether legally enforceable or not) to subscribe for or nominate persons tosubscribe for any shares or securities in any member of our Group.
11. Binding effect
This document shall have the effect, if an application is made in pursuance hereof, ofrendering all persons concerned bound by all of the provisions (other than the penal provisions) ofsections 44A and 44B of the Companies (WUMP) Ordinance so far as applicable.
12. Miscellaneous
(a) Save as disclosed in this document, within the two years immediately preceding the dateof this document:
(i) no share or loan capital of our Company or any of our subsidiaries has been issuedor agreed to be issued or is proposed to be fully or partly paid either for cash or aconsideration other than cash;
(ii) no share or loan capital or debenture of our Company or any of our subsidiaries isunder option or is agreed conditionally or unconditionally to be put under option;
(iii) no commissions, discounts, brokerages or other special terms have been granted oragreed to be granted in connection with the issue or sale of any share or loancapital of our Company or any of our subsidiaries;
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-40 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.
(iv) no commission has been paid or is payable for subscription, agreeing to subscribe,procuring subscription or agreeing to procure subscription of any share in ourCompany or any of our subsidiaries;
(b) save as disclosed in this document, there are no founder, management or deferred sharesnor any debentures in our Company or any of our subsidiaries;
(c) there has not been any interruption in the business of our Group which may have or hashad a significant effect on the financial position of our Group in the 12 monthspreceding the date of this document;
(d) the principal register of members of our Company will be maintained in the CaymanIslands by Ogier Global (Cayman) Limited and a branch register of members of ourCompany will be maintained in Hong Kong by [REDACTED]. Unless our Directorsotherwise agree, all transfer and other documents of title of Shares must be lodged forregistration with and registered by our Company’s share register in Hong Kong and maynot be lodged in the Cayman Islands. All necessary arrangements have been made toenable our Shares to be admitted to [REDACTED];
(e) no company within our Group is presently listed on any stock exchange or traded onany trading system;
(f) our Directors have been advised that the use of a Chinese name by our Company doesnot contravene the Cayman Companies Law; and
(g) our Company has no outstanding convertible debt securities or debentures.
13. Material adverse change
Our Directors confirm that, save for the matters disclosed in the section headed ‘‘Summary— Recent development and material adverse changes’’ in this document, there has been no materialadverse change in the financial or trading position or prospects of our Group since 31 December2019 (being the date to which the latest audited consolidated financial statements of our Groupwere made up) up to the Latest Practicable Date.
14. Bilingual document
The English language and Chinese language versions of this document are being publishedseparately in reliance upon the exemption provided by section 4 of the Companies Ordinance(Exemption of Companies and Prospectuses from Compliance with Provisions) Notice (Chapter32L of the Laws of Hong Kong).
APPENDIX V STATUTORY AND GENERAL INFORMATION
– V-41 –
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ INCONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER OF THIS DOCUMENT.